NEW FAMILY OF MAMMALIAN POTASSIUM CHANNELS, THEIR CLONING AND THEIR USE, ESPECIALLY FOR THE SCREENING OF DRUGS

Abstract: This invention relates to a new member of a recently recognized TWIK potassium transport channels, herein designated as TASK2. TASK2 is a unique potassium transport channel which is regulated by external pH and predominantly expressed in kidney and epithelial tissues. The invention relates to various constructs of TASK2 for the production of TASK2 and their uses for diagnostic tests and screening methods to identify compounds that modulate potassium transport.

Description: NEW FAMILY OF MAMMALIAN POTASSIUM CHANNELS, THEIR CLONING AND THEIR USE, ESPECIALLY FOR THE SCREENING OF DRUGS BACKGROUND OF THE INVENTION Cross-Reference to Related Applications This application claims the benefit of U.S. Serial No. 08/749,816, filed November 15, 1996 and entitled New Family of Mammalian Potassium Channels, Their Cloning And Their Use. Especially For The Screening of Drugs, U.S . Provisional Application Serial No. 60/095,234, filed August 4, 1998, entitled Task, a Human Background K+Channel to Sense External pH Variations Near Physiological pH y U.S. patent serial no.09/144,914 entitled Family of Mammalian Potassium Channels. Their Cloning and Their Use. Especially for the Screening of Drugs, filed August 5, 1 98 and provisional application serial no. 60/107,692, entitled Cloning and Expression of a Novel Ph-sensiiive Two Pore Domain K+channelfrom Human Kidney, filed on November 9, 1998. This application claims the benefit ofthe filing dates of these applications. These applications are incorporated herein by reference in their entirety Field Of Invention The present invention relates to a new family of potassium channels. More specifically, the invention relates to the cloning of new human potassium channels that constimte the members of anew functional and structural group of potassium channels. The abundance of these channels and their presence in a large number of tissues are such as to confer on them a fundamental role in the transport of potassium in a large number of types of cells. SUMMARY OF THE INVENTION Potassium channels are ubiquitous in eukaryote and prokaryote cells. Their exceptional functional diversity make them ideal candidates for a large number of biological processes in living cells (Rudy, B., 1988. Neurosciences, 25, 729-749: Hille, B., 1992, "Ionic Channels of Excitable Membrane", 2nd edition, Sinauer, Sunderland, Massachusetts). In excitable cells, the K+ channels define the form ofthe action potentials and the frequency ofthe electric activity, and play a major role in neuronal integration, muscle contraction or hormonal secretion. In nonexcitable cells, fheir expression appears to be correlated with specific stages of the development ofthe cell (Barrel, B. A. et al., 1990, Annul Rev. Neurosci., 13, 441-474). In most cells, specific types of K+ channels play a vital role in determining the electrical potential ofthe membrane at rest by regulating the membrane permeability to + ions. These channels exhibit the characteristic of being instantaneous and open in a large range of membrane potentials. Recent cloning studies have resulted in the identification of a large number of subunits capable of forming potassium channels (Betz, H., 1 90, Biochemistry, 29, 3591-3599; Pongs, 0., 1992,Physiol.Rev.,72,S6988;Salkoff,L. et al., 1992, Trends Neurosci., 15, 161-166; Jan, L. Y. and Y. N. Jan, 1994, Nature, 371, 199-122; Doupnik, C. A. et al., 1995, Curr. Opin. Neurobiol., 5, 268-277) which could be regulated by other types of subunits (Aldrich, R. W., 1994, Curr. Biol., 4, 839-840; Iso , L. L. et al., 1994, Neuron, 12, 1183-1194; Rettig, J. et al., 1994, Nature, 369, 289-294; Attali, B. et al., 1995, Proc. Nafl. Acad. Sci. USA, 92, 6092- 6096). The subunits ofthe voliage-dependent K+ channels activated by depolarization (Kv families) and the calcium-dependent K.+ channels exhibit six hydrophobic transmembranal domains, one of which (S4) contains repeated positive charges which confer on these channels their sensitivity to voltage and, consequently, in their functional outward rectification (Logothetis, D. E. et al., 1992, Neuron, 8, 531- 540; Bezanilla, F. and Stefani, E., 1994, Annul Rev. Biophys. Biomol. Struct., 23, 819- 846). The K+ channels with inward rectification (Kir families) have only two transmembranal domains. They do not have the S4 segment and the inward rectification results from a voltage-dependent blockade by cytoplasmic magnesium (Matsuda, H., 1991, Annul Rev. Physiol., 53, 289-298; Lu, Z. andMackinnon, R., 1994, Nature, 371, 243-246; Nichols, C. G. et al., 1994, J. Physiol. London, 476, 399- 409). A common structural unit, called the P domain, is found in both groups, and constitutes an essential element of the structure of the K+-permeable pore. The presence of this unit in a membrane protein is considered to be the signature o the structure of a K+ channel (Pongs, O., 1993, J. Membrane Biol., 136, 1-8; Heg botham, L. et al., 1994, Biophys. J., 66, 1061-1067; Mackinnom R, 1995, Neuron, 14, 889-892; Pascual, I M. et al., l995,Neuron, 14, 1055-1063). The present invention is based on the cloning of K+ channels which are the first members of a new structural and functional group of potassium channels. These new K+ chamels have a novel molecular architecture with four trans-membranal segments and two P domains. From a functional point of view, these channels are remarkable in that they exhibit different electrophysical properties. For example, one of these exhibits weak inward rectification properties. This new channel is referred to below as TWTK-1 following the English-language term "Tandem of P domains in a Weak Inward rectifying K+ channel". Its abundance and its presence in a large number of tissues are such as to confer on it a fundamental role in the transport of potassium in a large number of types of cells. In contrast, TASK1 and TASKL2 (TWIK-related Acid-Sensitive K+ channel) exhibit an outward rectification under low concentrations of potassium. The discovery of this new family of potassium channels and the cloning of new members of this family provides, notably, new means for screening drugs capable of modulating the activity of these new potassium channels and thus of preventing or treating the diseases in which these channels are involved. The research activities that led to the cloning of the TWD -1, TASK1 and TAS 2 channels was carried out in the manner described below with reference to the attached sequences and drawings in which: - SEQ ID NO: 1 represents the nucleotide sequence of the cDNA of TWIK4 and its deduced amino acid sequence. - SEQ ID NO: 2 represents the amino acid sequence of the TWIK-1 protein. - SEQ ID NO: 3 represents the nucleotide sequence of the cDNA of TASK1 and its deduced amino acid sequence. - SEQ ID NO: 4 represents the amino acid sequence of the TASK1 protein. - SEQ ID NO: 5 represents the nucleotide sequence of the cDNA of TASK2 and its deduced amino acid sequence. - SEQ ID NO: 6 represents the amino acid sequence ofthe TASK2 protein. DETAILED DESCRIPTION OF THE DRAWINGS Figure 1 represents the Northern blot analysis, the nucleotide sequences and the deduced amino acid sequence, as well as the hydrophobicity profile of TWIK-1 (SEQ ID No. 1). (a): expression of TWIK-1 mRNA in human tissues; each track contains 5 μg of poly(A)+ RNA; the autoradiograph was exposed for 24 hours, (b) cDNA sequence of TWIK-1 and the amino acid sequences ofthe coding sequence. The supposed transmembranal segments are circled and the P domains are underlined; D represents a potential glycosylation site and ■ represents the threonine residue in the consensus recognition site of protein kinase C. (c): the hydrophobicity analysis and the topology of TWIK-1 deduced from it; the hydrophobicity values were calculated according to the method of Kyte and Doolittle (window size of 11 amino acids) and are presented in relation to the position ofthe amino acid; the shaded hydrophobic peaks correspond to the transmembranal segments. Figure 2 represents the sequence alignments, (a): alignment ofthe P domains of TWIK-1, TOC/YORK and other representative K+ channel families (SEQ ID No. 9 through SEQ ID No.23); the identical and conserved residues are circled in black and in gray, respectively, (b): alignment of TWIK-1 (SEQ ID No.2) with potential homologs of; the sequences Ml 10.2 (SEQ ID No. 7) and F17C8.5 (SEQ ID No. 6) were deduced from the gene sequences (respective access numbers Z49968 and Z35719); the computerized splicing ofthe other genomic sequences of C. elegans (respective access numbers Z49889, P34411 and Z22180) is not sufficiently precise to allow their perfect alignment and is therefore not shown. Figure 3 shows the biophysical and pharmacological properties of K+ currents recorded by the imposed voltage technique on Xenopus oocytes that had received an injection of TWIK-1 cRNA; (a): the oocyte was maintained at a holding potential (HP) of -80 mV and the currents were recorded at the end of 1-s voltage jumps from -120 to +60 mV in 20 mV increments, (b): regular current-voltage relationship using the same technique as in (a), (c): potential reversal ofthe TWIK-1 currents E^) as a function o the external K+ concentration, (d) current tracings linked to +30 mV depolarizations starting at a holding potential (HP) of -80 mV in the absence (top tracing) and in the pres- ence (bottom tracing) of 1 mM of Ba 2 *\ (e): blocking effect of 100 μM of quinine, same protocol as in (d). (f) dose-response relationship ofthe blocking ofthe TWIK-1 currents by quinine. Figure 4 shows the influence ofthe expression of TWEEC-1 on the membrane potential, (a): dose-response relationships ofthe cRNA; top row = equilibrium state ofthe outward currents measured at +30 mV; bottom row - membrane potentials associated with the resting state, (b): effect of 100 μM of quinine on the membrane potential of an oocyte which did not receive an injection (left tracing) and that of an oocyte that received 20 ng of TWDC-l cRNA. (c): statistical evaluation ofthe depolarizing effects of 100 μM of quinine on oocytes that did not receive injections (left bars) and on oocytes that received injections of 20 ng of TWIK-1 cRNA (right bars); control (unfilled bar), + quinine (solid bars); each bar represents the mean +/- SD of 5 oocytes. Figure 5 shows the properties ofthe single TWDC-l channel, (a): current tracings recording in the input-output configuration to the membrane potentials indicated in the absence (m) or in the presence (.) of internal M 2+ (3 mM) and in symmetry with 140 mM of K+. (b): mean of curves I-V (n = 10). (c and d): open time of distribution obtained at +80 mV (top histograms) and at -80 mV (bottom histograms) in the presence of 3 mM Mg (c) or in the absence of Mg 2 * (d). Figure 6 shows the blocking ofthe TWIK-l channels by the internal pH. (a and b): blocking effect ofthe internal acidification on the TWIK-l currents, induced by perfusion of CO 2 ; (a) tracings of superimposed currents induced by a depolarization phase at -30 mV starting at HP = -80 mV, control (top tracing), effect when equilibrium is reached in the presence of CO 2 (bottom tracing); (b): graph (n = 5) showing the almost complete blockade ofthe TWTK-l currents induced by CO2; (c and d): internal acidification induced by the application of DNP (1 mM). (c): same protocol as in (a), control (top tracing) and after 5 minutes of application of DNP (bottom tracing); (d): graph (n = 4) indicating the percentage of TWDC-l current remaining after treatment with DNP. (e and f): imposed voltage (method: attached patch) under symmetrical conditions of K+ concentration (140 mM) maintained at +80 mV. (e) course over time ofthe effect of 1 mM of DNP (marked with arrow) on the activities ofthe single TWDC-l channel (f): graph (n = 4) showing the effect of DNP on the mean probability of opening NP 0 calculated during 1 minute of recording starting at the equilibrium state, (g): activities measured in the "inside-out patch" state at 80 mV at different internal pH values. Bar graph (n = 10) of NP 0 in relation to the internal pH. Figure 7 shows the activation ofthe TWDC-l channels by PMA, activator of protein kinase C. (a): perfusion of PMA (30 nM) for 10 minutes increases the TWDC-l current (top tracing) induced by a depolarization phase at +30 mV starting at HP = -80 mV, control current (top tracing), (b): graph (n = 5) showing the activation effect of PMA on the TWDC- 1 currents, (c and d): attached patch configuration under symmetrical K+ concentration conditions maintained at +60 mV; (c): course over time ofthe effect of 30 nM of PMA on the single channel activities; the recordings of the channel activity were performed with a rapid scanning before and after the application of PMA; (d): bar graph (n = 5) showing the activation effect of PMA on NP„. Figure 8 shows the nucleotide and deduced amino acid sequences of human TASKl (SEQ ID No. 3) and partial amino acid sequence of mouse TASKl (SEQ H> No. 5). Consensus sites for N-linked glycosylaUon (*) and phosphorylation by protein kinase C (n), protein kinase A (s) and tyrosine kinase (1) in human TASKl . These sites have been identified by using the prosite server (European Bioinformatics Institute) with the ppsearch software (EMBL Data library) based on the MacPattem program. The sequence of human and mouse TASKl have been deposited in the GenBank/EMBL database under the accession numbers AF006823 and AF006824, respectively. Figure 9 shows the sequence comparison and membrane topology of TWDC-related channels. A: Alignment of human TWDC-l (SEQ ID No.2), mouse TREK-1 (SEQ JD No.8) and human TASKl (SEQ ID No.4) sequences. Identical and conserved residues are shown in black and grey, respectively. Dashes indicate gaps introduced for a better alignment. Relative positions of putative transmembrane segments (Ml to M4) and P domains (PI and P2) of human TASKl are also indicated. The M1-M4 domains were deduced from a hydropathy profile computed with a window size of 11 amino acids according to the Kyte and Doolittle method (Kyte and Doolittle, 1982). B: Putative membrane topology of TWDC-l, TREK-1 and TASKl channels. Figure 10 shows the northern blot analysis of TASKl distribution in adult human tissues. Human multiple tissues Northern blots from Clontech were probed at high stringency with a TASKl cDNA probe. Each lane contains 2 μg of poly(A) RNA. Autoradiograms were exposed for 48 h at -70 °G. The blots were re-probed with a β-actin cDNA probe for control, sk. muscle: skeletal muscle, sm. intestine: small intestine, PBL: peripheral blood leukocytes. Figure 11 shows the distribution of TASKl mRNA in adult mouse. A: Northern blot analysis. Each lane contains 2 μg of poly(A) RNA. Autoradiograms were exposed for 72 h at -70 °C. The blots were re-probed with a β-actin cD A probe for control. B, C, DJ' n situ hybridization analysis from a coronal section at the level ofthe forebrain (B), the cerebellum (C), and the heart (D). Warmer colors represent higher levels of expression. CAI-CA3: fields CA1-3 of Ammon's horn, Cx: cerebral cortex, DG: dentate gyrus, Gl: granular layer, Hb: habenula, SM: substantia nigra, PLCo: postero lateral cortical amygdaloid nuclei, PVP: paraventricular thalamic nucleus,^: atrium, V: ventricule. Figure 12 shows the biophysical properties of TASKl in Xenopus oocytes and COS cells. A: TASKl currents recorded from a Xenopus oocyte injected with TASKl cRNA and elicited by voltage pulses from -150 mV to +50 mV in 40 mV steps, 500 ms in duration, from a holding potential of -80 mV in low (2 mM K ) or high K solutions (98 mM K ). The zero current level is indicated by an arrow. B: Current-voltage relationships. Mean currents were measured over the last 50 ms at the end of voltage pulses from -150 to +50 mV in 10 mV steps as in A. Modified ND96 solutions containing 2 mM K and 96 mM TMA were used, TMA was then substituted by K to obtain solutions ranging from 2 mM to 98 mM K . TASKl currents are not sensitive to external TMA, no changes were observed upon substitution of NaCl by TMA (data not shown). C: Upper panel: reversal potentials of TASKl currents as a function of external K concentration (mean -fcSEM, n = 3). Lower panel: slope conductance measured between +10 and +50 mV on current-voltage relations as in A, plotted as a function o the external K concentration (mean ±SEM, n = 3). The mean values were fitted with an hyperbola function. D: Theoretical current-voltage relation in the same conditions as in A calculated according to the following modified Goldman-Hodgkin-Katz (GHK) current relation: [κ*L «F 2 lK'] in - [rι out e-^ OT where is the potassium current, is me apparent permeability for K , K Q 5 the half maximum activation by K + , [K + ] out and [K ] in are the external and internal K concentrations, V m the membrane potential, F, R and T have their usual meanings. The classical GHK relation has been modified with to take into account the sensitivity of the conductance to external K . E: TASKl currents recorded from a transfected COS cell and elicited by voltage pulses from -150 mV to +50 mV in 40 mV steps, 500 ms in duration, from a holding potential of -80 V, in low (5 mM K + ) or high K + solutions (155 mM K + ). The zero current level is indicated by an arrow. F: Current- voltage relationships. Mean currents were measured over the last 50 ms at the end of voltage pulses ranging from -150 to +50 mV in 10 mV steps as in E. Solutions containing 5 mM K + and 150 mM TMA were used, TMA was then substituted by K to obtain solutions ranging from 5 mM to 155 mM K . Figure 13 shows the pH dependent regulation of TASKl in Xenopus oocytes and COS cells. A: Current-voltage relationships recorded from a TASKl -expressing oocyte with a ramp ranging from -150 mV to +50 mV, 500 ms induration, from a holding potential of -80 mV, in ND96 solution at pH 6.5, 7.4 or 8.4. Inset: Currents elicited by voltage pulses to +50 mV, 500 ms in duration, in the same conditions as above. The zero current level is indicated by an arrow. B: pH-dependence of TASKl activity in Xenopus oocyte recorded at -50, 0 and +50 mV (mean ±SEM, n = 3) as in A. Data were fitted with a Boltzman relation. C: Current-voltage relation recorded from a TASKl -expressing COS cell with a ramp ranging from -150 V to +50 mV, 500 ms in duration, from a holding potential of -80 mV, in 5 mM K solution at pH 6.1 , 7.4 and 8.4. Inset: Currents elicited by voltage pulses to +50 mV, 500 ms in duration, in the same conditions as above. The zero current level is indicated by an arrow. D: pH-dependence of TASKl activity recorded in COS cell at -50, 0 and +50 V (mean ±SEM, n - 3) as in C. Data were fitted with a Boltzman relation. Figure 14 shows the comparison ofthe TASK2 sequence with the cloned TWDC-related potassium channels. A) Nucleotide and deduced amino acid sequences of TASK2. The four potential transmembrane segments are boxed and the two P domains are underlined. A consensus site for N-linked glycosylation (*) in indicated. B) Dendrogram of the five 2P potassium channels cloned from mammals. Figure 15 shows the tissue distribution of TASK2 in human and mouse. A) multiple tissue Northen (MTN) blots were probed at high stringency with a TASK2 cDNA probe and reprobed with a β-actin probe as a control, sk, skeletal muscle; srα intestine, small intestine; PBL, peripheral blod lymphocytes. B) RT-PCR analysis from mouse tissues. The amplified products were analyzed by Southern blot using a specific TASK2 probe. To check the integrity of the cDNAs, a GAPDH fragment was amplified and separated by electrophoresis before staining with ethidium bromide. Figure 16 shows the TASK2 mRNA distribution in human adult kidney. In situ hybridization was performed with antisense (A) and sense (B) probes. Specific signal (A was observed over distal tubules and collecting ducts (indicated by stars in the tubular lumen), while a low non-specific labeling was apparent over the glomerulus (G) and proximal tubule (PT). Sense probe (B) gave a unifor signal. Magnification: X520. Figure 17 shows the chromosomal mapping ofthe TASK2 gene. Idiogram of human G- banded chromosome 6p and localization ofthe TASK2 gene relative to markers mapped in the Genebridge 4 Radiation Hybrid DNA panel from Research Genetics. Figure 18 shows the expression of TASK2 in COS cells and Xenopus oocytes. A) TASK2 whole cell currents recorded in transfected COS cells in 5mM or 155mM external K+, during voltage pulses ranging from - 150 to +50 in 50mV steps. The holding potential is -80 mV, the dotted lines indicate the zero current level. B) current voltage relationship recorded as in A, with voltage ramps ranging from -150 to +50 mV, 500 ms in duration. C) relationship between the reversal potential measured in COS cells and the external K+ concentration, data (mean ±SEM, n β 4) are shown with the linear regression. D) current voltage relationship recorded in a TASK2 expressing oocyte in 2mM external K+, with voltage ramps ranging from -150 to +50 mV, 500 ms in duration. Inset: currents recorded in 2mM external K+ during voltage pulses ranging from -150 to +50 in 50mV steps. The holding potential is -80 mV. E) single channel currents recorded in transfected COS cells in outside-outpatch at various potentials ranging from -80mV to +80mV, in 40mV steps. The dotted lines indicate the zero current level. F) single channel current potential relationships recorded as in (E) in5mM(n= 22) and in 155mM(n=19) exte4mal K+. Figure 19 shows the sensitivity of TASK2 currents to external pH. A) current voltage relationships deduced from currents elicitedby voltage pulses ranging from -150 to +50 in 50mV steps, 500 ms duration starting from a holding potential of -80mV, measured at three different external pH (6.0, 7.4, and 8.6). B) whole cell currents elicited as in (A). relationship between the currents measured at -50, 0, and +50mV and the external pH. Data (mean ±SEM) were fitted with a Bolzmann relation (pH - 7.8 ± 0.1, n = 17, at 50mV). D) effect of pH6.5, 7.3, and 9.1 on N.Po calculated from the mean single channel currents recorded in the outside-out patches at OmV during 30 s and from slope conductance between -20 and +20mV (n=5). F) effect of pH 6.5 t 7.3 and 9.1 on single channel currents recorded at OmV 0^=13). Cloning of TWIK-L The P domains of K+ channels were used to determine the corresponding sequences in the GenBank data base by means ofthe BLAST sequence alignment program (Altschul, S. F. et al., 1990, J. Mol. Biol., 215, 03-410). There was thus identified a 298 bp human Tag expressed sequence (EST, HSC3AH031), the deduced amino acid sequence of which includes a nonconventional "P-like" domain sequence: GLG in place of GYG as shown in Figure 2a. It was then envisaged that this EST sequence was a partial copy of a RNA coding a new type of K+ channel subunit. A DNA probe was prepared from this sequence in order to carry out hybridization with a Northern blot (Clontech) of multiple human tissues. A 1.9 kb transcript was thereby found in abundance, as shown in Figure la, in the heart and the brain and, at lower levels, in the placenta, the lung, the liver and the kidney. The DNA probe was used to screen a bank of kidney cDNA and four independent clones were obtained. The cDNA inserts of 1.8 to 1.9 kb of these clones all have the same open reading frame (ORE) containing a region identical to the 298 bp sequence of HSC3 AH031 and differing solely in the length of their noncoding 5' sequences. The TWDC-l coding sequence was amplified using a low-error rate DNA polymerase (Pwo DNA pal, Boehringer) and subcloned in the plasmid pEXO so as to yield ρEXO-TWDC-1. Mutations were performed using the whole plasmid pEXO-TWDC-1 with a highly reliable PCR extension kit (Boehringer) and two adjacent primers. One of these introduced a punctiform mutation in the DNIK- 1 coding sequence, changing the 161 Thr codon into a codon for alanine. The product of the PCR was linearized by the enzyme BamHI and the cRNA were synthesized using a T7 RNA polymerase (Stratagene). Preparation of the X. larvis oocytes and cRNA injection were carried out in accordance with the literature (Guillemare, E. et al., 1992, Biochemistry, 31, 1246312468, Primary Structure of TWIK-1 The following characteristics were demonstrated: - The sequences ofthe cDNA clones contain an ORF of 1011 nucleotides (SEQ ID No. 1) coding for a polypeptide of 336 amino acids (SEQ ID No.2) shown in Figure lb. - This protein has two P domains. - Other than the P domains, no significant alignment was seen between TWDC-l and a K+ channel recently cloned in yeast and which also has two P domains (Ketchum, K. A. et al., 1995, Nature, 376, 690-695). - Analysis ofthe hydrophobicity of TWDC-l, shown in Figure lc, reveals the presence of four transmembranal domains, designated TI to T4 - By placing the NH2 end on the cytoplasmic surface, in accordance with the absence of signal peptide, one obtains the topology model shown in Figure lc. - In this model, the two P domains are inserted in the membrane from the exterior in accordance with the known orientation of these loops in the K+ channels. - In addition, the general structural unit of TWDC-l is similar to the unit that one would obtain by making a tandem of two classical subunits rectifying the entry of a potassium channel. Like a classical inward rectifier, TWDC-l does not exhibit the highly conserved segment S4 which is responsible for the sensitivity to the membrane potential ofthe inward rectification of the K+ channels of the Kv family. - Aunusual large loop of 59 amino acids is present between Ml and Pi, such as to extend the length ofthe linker Ml-Pl ofthe extracellular side of the membrane. - A potential site of N-glycosylation is present in this loop. - Three consensus sites of phosphorylation are present at the N-terminal (Ser 19 for calcium calmodulin kinase II) and C-terminal (Ser 303 for casein kinase D) ends of the cytoplasmic domains, and in the M2-M3 linker (Thrl61 for protein kinase IT). - The alignment of the P_ domains of an important group of K+ channels is presented in Figure 2a. It shows that the regions constituting the pore selective for K+ are well conserved including the G residues in position 16 and 18 and three other residues indicating practically exclusively conservative changes in positions 7, 14 and 17. It is of interest to note that a leucine residue is present in the place of a tyrosine conserved in position 18 in the P2 domain of TWTK-l , or of a phenylalanine in position 17 of the P domain of the K+ channel of type eag. Functional Expression of Twik-1 For the functional study, the coding sequence of TWDC-l was inserted between the noncoding sequences 5' and 3 * of Xenopus globin in the vector pEXO (Lingueglia, E. et al., 1993, J. Biol. Chem., 269, 13736-13739). A complementary RNA (cRNA) was transcribed of this construction and injected in the oocytes of X. laevis. In a 0.3ml perfusion chamber, a single oocyte was impaled on two standard glass microelectrodes (0.5 - 2.0 MW) charged with 3 M KCI and maintained under voltage-clamp with a Dagan TEV200 amplifier. The bath solution contained 98 mM KCI, 1.8 mM CaCl 2 , 2 mM MgCl 2 and 5 mM HEPES at pH 7.4 with KOH. Stimulation ofthe preparation, data acquisition and analyses were carried out with the pClamp program (Axon Instruments) USA3. For the patch-clamp experiments, the vitelline membrane was removed from the oocytes as described in the literature (Duprat, F. et al., 1995, Biochem. Biophys. Res. Commun., 212, 657-663); the oocytes were then placed in a bath solution containing 140 mM KCI, 1.8 mM CaCϊ 2 , 2 mM MgCl 2 and 5 mM HEPES at pH 7.4 with KOH. The pipettes were filled with a strong K+ solution (40 mM KCI, 100 mM of potassium methane sulfonate, 1.8 mM CaCl 2 , 2 m M MgCl 2 and 5 mM HEPES adjusted to pH 7.4 with KOH). 100 μM of GdCl, was added to the pipette solution to inhibit the action of the activated channel. The inside-out patches were perfused with a solution containing 140 mM KCI, 10 mM CaCl 2 , 5 mM HEPES adjusted to pH 7.2 with KOH and 5 ra M EGTA added daily. The single channel signals were filtered at 3.5 kHz and analyzed with the Biopatch program (Big-Logic, Grenoble, France). A noninactivating current, free from noninjected cells, was measured by the imposed voltage technique, as shown in Figure 3a Kinetic activation of the current is usually instantaneous and cannot be resolved because it is masked by the capacitive discharge ofthe current recorded at the beginning ofthe impulse. The current-voltage relationship is linear above 0 mV and then saturates for a stronger depolarization ofthe membrane, as shown in Figure 3b. TWDC- 1 is therefore K+ selective. In the case of a replacement of the external K+ by Na+ or N-methyl-D-gluconate, the reversal ofthe potential ofthe currents follows the K+ equilibrium potential (EK), as shown in Figure 3c. In addition, a change by 10 in the concentration [(K)] 0 leads to a change of 56 +/- 2 mV in the inversion value ofthe potential, in accordance with Nemst's equation. As shown in Figure 3, the K+ currents of TWDC-l are inhibited by Ba ϊ+ (Figure 3d) with an IC Sύ value of 100 μM, by quinine (Figure 3e and 3f) and by quinidine (not shown) with respective IC 50 values of 50 and 95 μM. The TWDC-l currents are slightly sensitive to TEA and to the class ID antiarrhythmic agent tedisamil (30% inhibition for each, at 20 mM and 100 μM, respectively). Less than 10% inhibition was seen after application of 4-aminopyridine (1 mM), apamin (0.3 μM), charybdotoxine (3 nM), dedrotoxine (0.1 μM), clofilium (30 μM), amiodarone (100 μM) and glibenclamide (30 μM). The TWDC-l channel is not sensitive to the Kit channel openers cromakaline (100 μM) and pinacidil (100 μM). Figure 4 shows the effect of increasing the doses of injected TWDC-l cRNA on the independent expression ofthe time ofthe K+ currents and on the resting state ofthe membrane potential (F^). As soon as the current appears, the oocytes become increasingly polarized, reaching a value of E m close to E R , The amplitude ofthe TWDC-l current reaches values of 0.6 to 0.8 μM with the injection of 20 ng per oocyte. Higher doses of TWDC-l cRNA are toxic, leading to a reduction in expression. In oocytes that received 20 ng of cRNA, quinine is the best blocker of TWDC-l, inducing a noteworthy reversible depolarization (73 +/- 6 mV, n β 5) as shown in figures 4b and 4c. The Unitary Properties of the Twik-1 Channel Single channel current recordings, shown in Figure 5, in an inside-out patch configuration or in a whole cell configuration show that the TWDC-l channels assure the passage of influx or exit currents as a function, respectively, o f a depolarization or a hyperpolarization (Figure 5a). The current voltage relationship ofthe single channel, shown in Figure 5 b, shows a barely accentuated inward rectification in the presence of 3 mM (Figure 5) and 10 mM (not shown) of Mg 2'r on the cytoplasmic side. As shown in Figure 5b, this rectification disappears in the absence of internal M 2r . With 3 mM of internal Mg 2"1" , the mean duration of opening at +80 mV is 1.9 ms and the unitary conductance is 1 +/- 1 pS (Figure 5c). At -80 mV, the channels are oscillating with a mean duration of opening of 0.3 s, and a conductance value in creasing to 34 pS. The withdrawal of the internal Mg 24" ions does not influence the kinetic parameters under either polarized or depolarized conditions, but the unitary conductance measured at -80 mV reaches 35'+/- 4 pS. This apparent increase in conductance in the single channel suggests that it is the extremely rapid oscillation induced by Mg 2* that results in an underestimation ofthe real value of conductance. The same properties were observed in the fixed cell configuration, showing that the channel behavior is not modified by the excision of the patch. The TWDC-l channels in the excised patches do not discharge and do not appear to be deficient in intracellular constituents. In contrast to numerous channels which require the presence of ATP for their activity in the excised patch configuration, ATP is not required for the expression of TWDC-l. In addition, perfusion o the patch with a solution containing 10 mM of ATP does not induce any effect on the activity ofthe TWDC-l channel. Regulation of the TWIK-1 channel. The intracellular pH (pHj) is involved in the control of numerous cellular processes, and in cells such as the hepatic cells, the change in pHj regulates the membrane potential (Bear, C. E. et al., 1988, Biochi . Biophys. Acta, 944, 113-120). Intracellular acidification ofthe oocytes was produced using two methods: - superfusion with a solution enriched in CO 2 which produces acidification by a mechanism involving the bicarbonate transport system (GuiUemare, E. et al., 1995, Mol. Pharmacol., 47, 588-594); - treatment withdinitrophenol (DNP), which is a metabolic inhibitor that decouples the H+ gradient in mitochondria and induces internal acidity (Pedersen, P. L. and Carafoli, E., 1 87, Trends Biol. Sci., 12, 146-189). Both of these experimental methods resulted in a significant reduction in the TWDC-l currents, greater than 95% in the case of CO 2 and 80% in the case of DNP of the control amplitude values, as shown in Figures 6a to 6d. The inhibition induced by DNP on the activity of the single K+ channel was again observed under the attached patch conditions, as shown in Figures 6e to 6f.. However, after excision ofthe patch, the activity of the channel became insensitive to the acidification of the internal solution produced either by modifying the a 2 HPO 4 / H 2 PO 4 buffer ratio (Figures 6g and 6h3 or by bubbling of CO 2 (not shown). Thus, the effect ofthe pH value on the activity ofthe TWDC-l channel is probably indirect. Phosphorylation or dephosphorylation of specific amino acid residues is an important mechanism of regulation ofthe ionic channels (Levitan, I. B., 1994, Annul Rev. Physiol., 56, 193-212). As shown in Figure 7, activation of protein kinase C by phorbol-12 myristate acetate (PMA, 30 nM) increases the TWDC-l currents. The inactive phorbol ester 4α-phorbol-12, 13 didecanoate (PDA, 1 μM) has no effect. In an attached patch which initially expressed solely a single channel, application of PMA showed the presence of at least five channels (Figure 7c and 7d). This experiment shows that at least four channels are silently present in the patch before the application of PMA. Since the TWDC-l sequence contains a consensus phosphorylation site for protein kinase C (PKC), located at the level ofthe threonine in position 161 (Figure lb), the effect of PMA suggests regulation under the control of PKC. However, the mutation of the threonine 161 into alanine leads to a muted channel which remains functional and conserves the capacity to be activated by PMA. Activation of protein kinase A by application of 8-Cl-AMPc (300 μM) or forskolin (lOμM) does not affect the activity of TWDC-l . Elevation ofthe cytoplasmic C z ' concentration by application of A23187 (1 μM) which could be activated by Ca2+-cabnodulin kinase E and/or reveal the presence of a channel activated by the Ca 21" , is also without effect on the properties of the TWDC-l channel. TASKL a homolog of TWIK-1 TWDC-l and TREK-1 sequences were used to search for homologs in gene databases by using the tBlastn sequence alignment program (Altschul et al. , 1990). Translation of two overlapping EST sequences (GenBank accession numbers W36852 and W36914) in one frame exhibited significant sequence similarities with both TWDC- 1 and TREK- 1. A 560 bp DNA fragment was amplified by PCR from mouse brain poly(A) cDNAs and subcloned into pBluescript 32 (Stratagene) to give pBS-852/914. This fragment was P-labelled and used to screen mouse brain and heart cDN A libraries. Filterswerehybridizedandwashed as previously described (Fink et a 1996b). Eight positive clones from brain and ten from heart were obtained. cDNA inserts were characterized by restriction analysis and by partial or complete sequencing on both strands by the dideoxy nucleotide chain termination method using an automatic sequencer (Applied Biosystems). All the clones were shown to only contain a partial ORF. The cDNA insert ofthe 32 longer mouse clone (designated pBS-mTASKl ) was P-labelled and used to screen a human kidney cDNA library. Two independent hybridizing clones were isolated and sequenced. Both clones (2.5 kb long) were shown to contain the full-length ORF. The longer one was designated pBS-hTASK . Both cDNAs contain an ORF of 1185 nucleotides(SEQ ID No.3) encoding a polypeptide of 394 amino acids (SEQ O No.4) (Figure 8). The human protein sequence contains consensus sites for N-linked glycosylation (residue 53), and phosphorylation by protein kinase C (residues 358 and 383), tyrosine kinase (residue 323) and protein kinase A (residues 392 and 393). AU these phosphorylation sites are located in the C-terminus part ofthe protein. Except for a 19 residues cluster (aa 276 to 294 in the human sequence), mouse and human proteins share ahigh overaU sequence conservation (85% ofidentity) indicating that they probably are products of ortholog genes. Sequence alignments presented in Figure 9 clearly show that the cloned protein is a new member ofthe TWDC related K + channel family. Like TWDC-l (SEQ tt> No.2) and TREK-1 (SEQ ID No. 8), TASKl (SEQ ID No. 4) has four putative transmembrane segments (Ml to M4) and two P domains (PI and P2) (Figures 9A and 9B). TASKl is 58 amino acids longer than TWDC-l and 24 amino acids longer than TREK-1 because its C-terminus is more extended. Tissue Distribution of TASKl The expression of TASKl in adult human and mouse tissues was examined by Northern blot analysis. For Northern blot analysis, poly( A) RNAs were isolated from adult mouse tissues and blotted onto nylon membranes as previously described (Lesage et al, 1 92). The blot was probed 32 under stringent conditions with the P-labelled insert of pBS-mTASKl in 50% formamide, 5X SSPE (0.9 M sodium chloride, 50 mM sodium phosphate (pH 7.4), 5 mM EDTA), 0.1% SDS, 5X Denhardt's solution, 20 mM potassium phosphate (pH 6.5) and 250 μg denatured salmon sperm DNA at 50°C for IS h and washed stepwise at 55 β C to a final stringency of 0.2X SSC, 0.3% SDS. For hybridization of human multiple tissues Northern blots from Clontech, the procedure was identical except that the probe was derived from pBS-hTASKl . The cDNA insert of pBS-hTASKl contains different repeat sequences (AluJb, M t and (CGG)n) in the untranslated regions (UTR) and a Small Apάl restriction fragment of 1390 bp spanning the coding sequence was chosen as a probe that does not contain these repeats. Three different transcripts were detected in the human tissues with estimated sizes of 6.8, 4.2 and 2.6 kb (Figure 10), the shorter one having the same size that the cloned cDNAs. The two other transcripts (4.2 and 6.8 kb) may result from alternate polyadenylation signals in the 3 * non-coding sequence and/or correspond to alternatively spliced or immature forms ofthe transcript. TASKl is expressed in many different tissues but is particularly expressed in pancreas and placenta. Lower levels of expression were found in brain > lung, prostate > heart, kidney > uterus, small intestine and colon. As shown in Figure 11A, the TASKl probe detected a single transcript in the mouse with an estimated size of 4.2 kb. TASKl is expressed in heart >lung > brain and kidney. No expression was seen in liver and skeletal muscle. The TASKl distribution was further studied in adult mouse brain and heart by in situ hybridization. In situ hybridization experiments were performed on adult Balb/c mice by using standard procedures (Fink et al., 1996b). An antisense oligonucleotide (48 mer, S'-CACCAGCAGGTAGGTGAAGGTGCACACGATGAGAGCCAACGTGCGCAC-S*) (SEQ ID No.24) complementary to the mouse cDNA sequence of TASKl (from nucleotides 7 to 54) was used to detect the expression of TASKl transcripts in frozen fixed brain sections (10 μm). The probe was 3'-end-labelled with (o- 33 P)dATP. Sections were digested with 5 μg/ml of proteinase K for 15 min at 37 °C, acetyled for 10 min in 0.25% acetic anhydre in O.t M triethanolamine. Hybridization was carried out overnight at 37 °C in 2X SSC, 50% formamide, 10%dextran sulfate, lXDenhardt's solution, 5% sarcosyl, 500 g denatured salmon sperm DNA, 250 mg ml yeast tRNA, 20 mM dithiothreitol, and 20 mMNaPO 4 with 0,2 ngml of radiolabelled g probe (specific activity = 8.10 dpm μg). Slides were then washed in IX SSC before dehydratation, drying, and apposition to hyperfilm- β max (Amersham) for 6 days. The specificity of labelling was verified by in situ hybridization using cold displacement of radioactive probe with a 500-fold excess of unlabelled oligonucleotide. A wide and heterogeneous pattern of expression was obtained in the brain (Figures 11B and HC). TASKl mRNA was detected throughout the cell layers ofthe cerebral cortex, in the CA1-CA4 pyramidal cell layer, in the granule cells ofthe dentate gyrus, in the habenula, in the paraventricular thalamic nuclei, in the amyloid nuclei, in the substantia nigra and in the Purkinje and granular cells ofthe cerebellum. In the heart, a high level of TASKl expression was found in the atria (Figure 11D) while ventricular cells did not express this channel. Biophysical properties of TASKl currents in Xenopus oocytes. For functional studies, TASKl cRNAs were injected into Xenopus oocytes. This was accomplished by subcloning a 2480 bp SmaVXhol fragment from pBS-hTASKl containing 14 bp of 5' UTR, the coding sequence and the entire 3' UTR into the pEXO vector (Lingueglia et al, 1993) to give pEXO-TASKl. Capped-cRNAs were synthesised in vitro from the linearized plasmid by using the T7 RNA polymerase (Stratagene). Xenopus laevis were purchased from CRBM (Montpellier, France). Preparation and cRNA injection of oocytes has been described elsewhere (Guillemare et al, 1992). Oocytes were used for electrophysiological studies 2 to 4 days following injection (20 ng oocyte). L a 0.3 ml perfusion chamber, a single oocyte was impaled with two standard microelectrodes (1-2.5 MΩ resistance) filled with 3 M KCI and maintained under voltage clamp by using a Dagan TEV 200 amplifier, in standard ND96 solution (96 mM NaCl, 2 mM KCI, 1.8 mM CaCl 2 , 2 M MgCl 2 , 5 mM HEPES, pH 7.4 with NaOH). In some experiments, NaCl was substituted with TMA Cl (Tetra Methyl Ammonium Chloride). Stimulation ofthe preparation, data acquisition, and analysis were performed using pClamp software (Axon instruments, USA). Drugs were applied externally by addition to the superfusate (flow rate : 3 ml/min) or intracellularly injected by using a pressure microinjector (Inject+Matic, Switzerland). AU experiments were performed at room temperature (21-22 °C). A non-inactivating current, not present in uninjected oocytes (not shown), was measured by two-electrode voltage-clamp (Figure 12A). Activation kinetics of the TASKl current are almost instantaneous (under 10 ms). The current-voltage (I-V) relationship is outwardly-rectifying and almost no inward currents were recorded in the ND96 external medium containing 2 mM K (Figure 12B). However, inward currents were revealed when the external K + concentration ([K ] out ) was gradually increased to 98 mM K (Figures 12A and 12B). Figure 12A presents the I-V relationships ofthe current in K -rich solutions ranging from 2 mM to 98 mM. The relationship between the reversal potential and [K τ ] out was close to the predicted Nernst value (52.1 mV/ decade, n = 4) as expected for highly selective K 1" channel (Figure 12C, upper panel). On the other hand, external K enhanced the outward currents in a concentration-dependent manner as illustrated in Figure 12C (lower panel). The half maximum activationby K was observed at a KQ of 2.06 mM. The theoretical I-V relationships in various (K ] out calculated according to the Goldman-Hodgkin- atz current equation are shown in Figure 12D. These I-V relationships are very close to the I-V relationships corresponding to recorded TASKl currents (Figure 12A). This strongly suggests that TASKl currents show no rectification other than mat predicted from the constant-field assumptions and that TASKl lacks intrinsic voltage-sensitivity. The slight deviation between experimental and theoretical points are probably due to small endogenous chloride conductance and or a K loading ofthe oocytes. We have previously shown that oocytes expressing TWDC-l or TREK-1 are more polarized that control oocytes, the resting membrane potential (E-.,) reaching a value close to the K equilibrium potential (E jj j. In oocytes expressing TASKl , E m was -85 ±0.8 mV (n = 23, in standard ND96) instead of - 44 ±2.6 V (n *= 9) in non-injected oocytes. This result demonstrates that TASKl, like other TWDC or TREK channels, is able to drive F^ close to E κ . The effect of various pharmacological agents on currents elicited by voltage pulses to +50 mV has been studied in TASKl-expressing oocytes. Less than 20% of TASKl currents were inhibited in the presence of quinine (100 μM), quinacrine (100 μM) or quinidine (100 μM). The "classical" K channels blockers tetraethylammonium (TEA, 1 mM) and 4-aminopyridine (4AP, 1 mM) were also inactive. Cs + (100 μM) induced a voltage-dependent block of 31 ±2% (n = 4) of the inward current, recorded a -150 mV, in 50 mM external K + .In the same conditions, Ba 2+ (100 M)was ineffective with a variation of 6 ±1% (n = 4) of the inward current. Biophysical properties of TASKl channel in transfected COS cells. The 2480 bp SmaVXhol fragment of pBS-TASKl was subcloned into the pCi plasmid (Promega) under the control ofthe cytomegalovirus promoter to give pCi-TASK COS cells were seeded at a density of 70,000 cellsper 35 mm dishes 24 h prior transfection. Cells were then transfected by the classical calcium phosphate precipitation method with 2 μg of CI-TASKl and 1 μg of CD8 plasmids. Transfected cells were visualized 48 h after transfection using the anti-CD8 antiboby coated beads method (Jurman et al, 1994). For electrophystological recordings, the internal solution contained 150 mM KCI, 3 mM MgCl 2 , 5 mM EGTA, and 10 mM HEPES at pH 7.2 with KOH, and the external solution 150 mM NaCl, 5 mM KCI, 3 mM MgCl 2 , 10 mM HEPES at pH 7.4 with NaOH. Untransfected cells did not express this K channel activity (not shown). Figure 12E shows whole cell currents recorded in the mammalian COS cells transiently transfected with TASKl , in external solutions containing 5 mM and 155 mM K . The current were instantaneous and non-inactivating as in Xenopus oocytes. Figure 12F presents the I-V relationships of TASKl current in various external K concentrations. The currents show the same Goldman-Hodgkin-Katz type outward rectification as in oocytes. Regulation of the TASKl channel. TASKl currents were insensitive to internal Ca 2+ changes obtained by injection of inositol triphosphate (IP3, 1 mM) or EGTA (100 mM), to the activation of adenyl cyclase by perfusion of DJMX (1 mM) and forskolin (10 μM), or to the activation of protein kinase C (PKC) by application of the phorbol ester PMA (40 nM). TASKl currents were insensitive to the internal acidification or alkalisation obtained by injection of solutions at pH 2 or 8.7 respectively (n = 3). However, their very interesting property is that they are highly sensitive to external pH. The current-potential relationships recorded from a TASKl -expressing oocyte at pH 6.5, 7.4 and 8.4 are presented in Figure 13A. For an external pH of 6.5, a drastic block was observed at all potentials while an activation was recorded at pH 8.4, also at all potentials. The inhibition and activation produced no modification of current kinetics (Figure 13 A, inset). The pH-dependence ofthe TASKl channel is shown in Figure 13B. For currents recorded at +50 mV, the inhibition by acidic pHs was characterised by an apparent pK of 7.34 ±0.04 units (n = 3) and a Hill coefficient of 1.54 ±0.08 (n = 3). For currents recorded at 0 and -50 mV, the pKs were 7.32 ±0.02 and 7.30 ±0.01 respectively (n - 3) showing that the blocking effect of external protons is not voltage-dependent The resting membrane potential ofTASKl -expressing oocytes was -84 ±1 mV (n = 6) at pH 7.4 and shifted to -47 ±6 mV (n ~ 6) at pH 6.4 (not shown). Finally, Figures 13C and 13D show that the strong pH sensitivity ofTASKl currents was also observed in transfected COS cells. A large inhibition or activation of the current was recorded, at all potentials, when pH was changed from 7.4 to 6.1 or 7.9 respectively (Figure 13C). The kinetics ofthe current were unmodified at both pH (Figure 6C, inset). Figure 13D shows that the pH effects were also non voltage-dependent in COS cells. The external pH-dependence ofTASKl, at +50 mV, indicates a pK value of 7.29 ±0.03 (n - 5) and aHilϊ coefficient of 1.57 ±0.07 (n - 5). Currents recorded at 0 and -50 mV presented pKs of 7.29 ±0.04 (n = 5) and 7.32 ±0.05 (n = 4) respectively. 10% of he maximum current was obtained at pH 6.68 ±0.08 (n = 4) and 90% at pH 7.66 ±0.05 (n = 4). These results confirm that TASKl is extremely sensitive to extracellular pH in the physiological range. Additional non-mammalian homologs of TWIK-1 Comparison ofthe complete sequence of TWDC-l (SEQ ID No. 1) with the sequences of the Genbank data base allowed identification of at least five genes of Caenorhabditϊs elegans, which had been characterized in the context o the Nematode Sequencing project, which may encode additional structural homologs of TWDC-l. The alignment of two of these homologs (SEQ JD No. 6 and SEQ JX> No. 7) with TWDC-l (SEQ ID No. 2) is shown in Figure 2b. The degree of similarity between the deduced protein sequences of C. elegans and TWDC-l are approximately 55 to 60%. Amino acid sequence identities among the deduced polypeptide sequences range from 25 to 28%. Interestingly, the degree of similarity and amino acid sequence identity of the various C. elegans are not greater than what was determined for TWTK- 1. These results indicate that other TWDC-l related potassium channels maybe present in the C. elegans genome and suggest that additional members ofthe 2P family of potassium channels may exist in mammals. Additional mammalian homologs of TWIK-1. the identification of TASK2 Indeed, the method described above has also led to the identification of a human EST (GenBank accession number H01932) that exhibits similarity to the MlPl extracellular loop of TWDC-l. The 5' end of this EST encoded the PI andM2 domains of a two P domain channels as expected. We postulated that this EST was a tandem cDNA or was issued from an unspliced mRNA, and we used only the 5* part of the sequence to design oligonucleotides. These oligonucleotides were further used to cany out 3 -RACE PCR experiments on human brain cDNA by standard methods. A DNA fragment was obtained that extended the region homologous to TWDC-l and previously identified in H01932. Two novel oligonucleotides were deduced from the homologous part of this DNA fragment: sense strand, 5'- CACAGAAGCTGCATCTGCTCA^ (SEQ ID No. 25); antisense strand, 5'-CCCTCAGTCTCCATGAATAGGA-3' (SEQ ff> No.26). They were used to amplify a 430 bp fragment that was 32 P-labeled and used to screen a human kidney cDNA library as previously described (8). The screening of 3 x 10 s phages yielded 37 positive clones. Seven clones were excised from λZAPD XR vector into pBluescriptD SK- (pBS), and were analyzed by restriction analysis and by sequencing of their extremities. The longer cDNA insert (ρBS-TASK-2) was completely sequenced on both strands by using the dideoxy nucleotid termination method using an automatic sequencer (Applied Biosystem, model 373 A). The full length cDNA of 3.5 kb (SEQ ID No. 27) contains an extended open reading frame that codes for a polypeptide of 499 residues (SEQ ID No. 28) with a calculated MW of 55.2 kDa. The predicted product displays all the hallmarks of the 2P domain * channels (Fig. 14A). Analysis of its hydropathy profile indicates the presence of four TMS noted Ml to M4, the Ml and M2 segments flanking a first P domain (PI) and the M3 and M4 flanking a second P domain (P2). An extended MlPl interdomain which is characteristic of this channel family is also found that is expected to be extracellular as forTWDC- 1. This region contains a potential N-linked glycosylation site as well as a cysteine residue (position 51), that is conserved in several other 2P potassium channels. In TWDC-l (SEQ ID No.2), this cysteine residue has been shown to be implicated in the formation of an interchain disulfide bond (25). Despite this overall structural conservation, the novel subunit is only distantly related to the other cloned 2P domain K + channels (between 18 and 22% of amino acid identity). The dendrogram shown in Fig. 14B also suggests that the novel subunit is not more related to TASK than to TWDC-l , TREK-1, or TRAAK. However, it was called TASK-2 (SEQ D No. 27) to emphasize the fact that it produces K τ currents that are Acid- Sensitive like TASK- 1 as shown below. For this reason, TASK is now called TASK-1 (SEQ ID No.4). Tissue distribution of TASK-2 The tissue distribution of TASK-2 in adult human was analyzed by Northern blot and RT- PCR, Human Multiple Tissue Northern (MTN) blots were purchased from Clontech and hybridized at 65 °C in ExpressHyb solution with 0.6 and 1.2 kb Smal J2 P-labeled fragments from pBS-TASK-2 following the manufacturer's protocol. For RT-PCR experiments, total RNAs were extracted from adult mouse tissues and from mouse embryos with the SNAP total RNA isolation kit (Invitrogen). After a DNAse treatment, 15 μg of total RNA were reverse- transcripted according to the manufacturer's instructions (Gibco BRL). 1/40 μl of each sample were used as template for PCR amplification (Taq DNA polymerase, Gibco BRL) by using TASK-2 (base positions 358-381 : S'-CTGCTCACCTCGGCCATCATCTTC-3' (SEQ ID No.29) and 901-924: 5'-GTAGAGGCCCTCGATGTAGTTCCA-3' (SEQ ID No. 30) and GAPDH (Clontech) primers. PCR conditions were 30 cycles of 30 sec at 94°C, 30 sec at 60°C, and 30 sec at 72 Q C. TASK-2 amplified fragments were transferred onto nylon membranes then probed at high stringency (50% aqueous formamide at 50°C) with a 32 P-labeled S al DNA fragment of pBS-TASK-2 (nt 116 to 1305). ϊnsitu hybridization was performed as previously described ( 1 ) on 7μm paraffin sections of human kidneys fixed in 4% paraformaldehyde. A specific anti-sense cRNA probe was generated with T7 RNA polymerase (Promega), by in vitro transcription using 3s S-α-UTP from a JcoRI-linearized plasmid containing a 337 bp NcoVClal fragment of the 5'-untranslated sequence of TASK-2 cDNA inserted into pBS. The same plasmid was linearized by Xhol and T3 RNA polymerase was used for the synthesis of a control sense probe. The probes were hybridized, then slides were covered with NTB2 emulsion (Kodak) and exposed for 32 days at -20 °C. Typical stringent hybridization conditions are described above; typical non-stringent conditions contain lower concentrations of formamide (0 - 30% formamide), or a solution comprising 6 X SSC, 5 X Denhardt's solution at 60°C. After development, slides were stained with toluidine blue and photographed. The fragments of human kidney were obtained from surgical ablation of renal cancers (pieces of tissues surrounding the tumor). Northern blotting (Fig. 15 A) showed that a 4 kb transcript is abundantly expressed in the kidney and is present to a lesser extent in the pancreas, the liver, the placenta, and the small intestine. The expression of TASK-2 was also analyzed by RT-PCR from mouse tissues (Fig. 15B). The mouse TASK-2 message was found in the kidney, the liver, and the small intestine, in the same relative abundance as inhuman. As expected, the RT-PCR method is more sensitive than the Northern blot technique, and faint positive signals were also obtained in mouse brain- heart, skeletal muscle and colon. Surprisingly, TASK-2 expression levels in uterus, lung and pancreas are different between human and mouse. Figure 15B compares the distribution of TASK-2 to those ofthe other cloned 2P domain K + channels, TWDC-l , TREK- 1 , and TASK- 1. As shown previously by Northern blot analyses, the TWIK-1, TREK-1, and TASK-1 channels are widely distributed but with unique patterns. The expression pattern of TASK-2 is also unique. TASK-2 is preferentially expressed in the kidney and the liver, and is quasi absent in the nervous system, unlike TWtK-1, TREK-1, or TASK-1 (Fig. 15B). TRAAK is exclusively expressed in neuronal cells (12). Both Northern blot and RT-PCR analyses indicate that the tissue that expresses the highest levels of TASK-2 is the kidney. The distribution of TASK-2 in the human kidney cortex was observed at a higher resolution after in situ hybridization. Fig. 16 shows that the expression of TASK-2 is restricted to the distal tubules and the collecting ducts. No specific signal was observed in the proximal tubules or over the glomeruli. Chromosomal mapping of TASK-2 The chromosomal assignment of human TASK-2 was carried out by Radiation Hybrid panel analysis. The Genebridge 4 RH DNA panel (Research Genetics) was screened by PCR using primers deduced from the 3'-untranslated part of TASK-2 cDNA (sense primer, 5'- CTTCCTAACCTTCCATCATCC-3'(SEQIJ- No.31) annealsto base positions 1971-1991,and theaπtisenseprimer, 5'-CTTGACCTGAGAGAGGGAAC-3'(SEQIX ) NO.32) anneals to bases 2455-2564. PCR conditions were as follows: 40 cycles of 30 sec at 94 °C, 30 sec at 50 ° C, 30 sec at 72°C. PCR products were separated by electrophoresis on agarose and transferred onto charged nylon membranes. Blots were probed at high stringency (e.g., 50% aqueous formamide at 45°C) with a 3 P-labeled DNA probe spanning the amplified region ofthe TASK-2 gene. The results were analyzed by using RHMAPPER program at the Whitehead Institute (www- genome.wi.mitedu). As shown in Fig. 17, the gene encoding TASK-2 lies on chromosome 6p and is 5.45 cR centromeric to the framework marker Wl-4142 (LOD score of 21). Although radiation hybrid maps are not anchored to the cytogenic maps, the most likely localization o the TASK-2 gene is 6p21.3l-p2l.33. TWDC-l has been previously mapped to chromosome Iq42-lq43 (26), and TREK and TASK to chromosomes l 41 and 2p23, respectively (27). Biophysical and pharmacological properties of TASK-2 The sequence coding for TASK-2 was amplified by PCR using a low error rate polymerase (Pwa polymerase, Boehringer Mannheim) and subcloned into the pEXO vector (22) to give pEXO-TASK. Capped-cRNAs were synthesized in vitro from the linerarized plasmid by using the T7 RNA polymerase (Stratagene). Xenopus laevis were purchased from CRBM (Montpellier, France). Preparation and cRNA injection of oocytes has been described elsewhere (23). Oocytes were used for electrophysiological studies 2 to 4 days following injection (20 ng oocyte). In a 0.3 ml perfusion chamber, a single oocyte was impaled with two standard microelectrodes ( 1 -2.5 MΩ resistance) filled with 3 M KCI and maintained under voltage clamp by using a Dagan TEV 200 amplifier, in standard ND96 solution (96 mM NaC 1 , 2 mM KCI, 1.8 mM CaCl 2 , 2 mM MgCl 2 , 5 mM HEPES, pH 7.4 with NaOH). Stimulation ofthe preparation, data acquisition, and analysis were performed using pClamp software (Axon instruments, USA). Drugs were applied externally by addition to the superfusate (flow rate: 3 ml min). All experiments were performed at room temperature (21-22°C). For patch clamp analyses, aNotl/EcόRI fragment of 3.2 kb was excised from pBS-TASK- 2 and subcloned into the pH*ES-CD8 vector to givepIREScd8-TASK-2. The ρlRES-CD8 vector was obtained by replacing the neo R gene in the original vector pIRESneo (Clontech) by the coding sequence ofthe T type lymphocyte's surface marker CD8. COS cells were seeded at a density of 20,000 cells per 35 mm dishes 24 h prior to transfection. Cells were then transiently transfected by the classical DEAE-dextran method with 1 μg of p)REScd8-TASK-2 plasmid per 35 mm dish. Transiently-transfected ceUs were visualized 48 h after transfection using the anti- CD8 antibody coated beads method (24). For whole cell recordings, the internal solution contained 150mM KCI, 3 mM MgCl 2 , , 5 mM EGTA, and 10 mM HEPES at pH 7.2 withKOH, and he external solution 150 mM NaCl, 5 mM KCI, 3 mM MgCl 2 , 1 mM CaCl 2 , 10 mM HEPES at pH 7.4 with NaOH. TASK-2-transfected COS cells display non-inactivating currents (Fig. 18A) that are not present in control cells (not shown). The activation kinetics ofTASK-2 currents are rapid. They are fitted with a single exponential characterized by time constants of 60.9 ± 6ms at +50 mV and 62.6 + 6 ms at OmV (n = 8). The current-voltage (I-V) relationship is outwardly-rectifying and almost no inward currents were recorded in an external medium containing 5mM K " (Fig. 18B). When cells were perfused with a K + -rich solution (155mM), the TASK-2 currents presented an almost linear I-V relationship and the inward currents recorded at very negative potentials were noisy (Fig. 18A, 18B). The relationship between the reverse potential and [K + ] <> is close to the predicted Nerπst value (58.9 + 4.5 mV / decade, n = 4) as expected for a highly selective K + channel (Fig. 18C). TASK-2 was also expressed in Xenopus oocytes where it shows similar properties (Fig. 18D). Activation kinetics ofthe TASK currents in oocytes are slightly slower, with time constants of 112.6 + 16.8 ms at +50 mV and 102.9 + 7.3 ms at 0 mV (n = 6). As previously shown with TWDC-l, TREK-1, TRAAK and TASK-l (8, 10-12), the membrane potential o f oocytes expressing TASK-2 is strongly polarized, ( -78.6 ± 2.7 V, n = ) compared to control oocytes (-42.2 + 3.1 mV, n = 6). Single channel TASK-2 currents were recorded in outside-out patches from transfected COS cells. They are very flickery and show substates (Fig. 18E). In 5 mM external K + , the single channel I-V relationship is almost linear between -80 and +40 mV and presents a saturation at potentials more positive than +40 mV (Fig. 18F). The slope conductance measured between -60 V and +20 mV is 14.5 + 1.4 pS (n = 22). In 155 mM external K + , the slope conductance is greatly increased (59.9 + 3.1 pS, n = 19) and saturates both at very negative and positive potentials. The effects of various pharmacological agents on currents elicited by voltage pulses to +50 mV have been studied in TASK-2-expressing COS cells. The "classical" K + channels blockers tetraethylammonium (TEA, 1 mM), 4-aminopyridine (4-AP, 100 μM) and Cs* (1 mM) were inactive on the recorded currents. Ba 2 " only slightly diminished the current at +50 mV (16.9 + 1.6% at 1 mM, n = 3). Quinine induced a dose-dependent inhibition of TASK-2 currents characterized by an IC S0 of 22.4 ± 1.8 μM (n = 9) (not shown) whereas 100 μM quinine induced a 65 + 3.8% inhibition ofthe current (n = 4). A strong effect was observed with lidocaϊhe (1 mM) and bupivacaϊne (1 mM) with inhibitions of 60.4 + 1.5% and 80.9 + 4.5%, respectively (n = 4). Zinc (100 μM) was also tested and induced a slight decrease of the current (15.3 + 2.2%, n = 5). On the contrary lo TRAAK (12), TASK-2 is not sensitive to arachidonic acid (10 μM). Regulation of TASK-2 activity by external pH TASK-2 currents were insensitive to the activation of adenyl cyclase obtained by increasing intracellular cAMP with a cocktail of IBMX (1 mM) and forskolin (10 μM), or by perfusion of the permanent 8-chloro cAMP (500 μM), or to the activation of PKC obtained by an application o the phrobol ester PMA (70 nM). Interestingly, TASK-2 currents are highly sensitive to external pH, like TASK-l (11). The I-V relationships recorded at pH 6.0, 7.4, and 8.6 are presented in Fig. 19N For an external pH of 6.0, a drastic block was observed at all potentials while an activation was recorded at pH 8.6, also at all potentials. The inhibition and activation produced no modification of current kinetics (Fig. 19B). The pH-dependence of the TASK-2 channel is shown in Fig.l9C. For currents recorded at -50 mV, 0 mV and +50mV the inhibition by acidic pHs was characterized by pHm values (for 50% of inhibition) of 8.6 + 0.1, 8.3 + 0.1 and 7.8 + 0.1 units, respectively (n = 6). The Hill coefficient at +50 mV is 0.69 + 0.09 (n - 6). Fig. 19D shows the pH sensitivity of TASK-2 single channel currents in the outside-out configuration. A large inhibition ofthe current was recorded at pH 6.5 and an increase atpH 9.1. Fig. 19E shows that the pH effects are due to a variation in N.Po and not in the single channel conductance (Fig, 19F). 10% ofthe maximum current was obtained at pH 6.5 + 0.1 (n - 6) and 90% at pH 8.8 ± 0.1 (n = 6). These results indicate that TASK-2 is very sensitive to extracellular pH in the physiological range. Unique structural features of 2P family of potassium transport channels. The overall level of amino acid sequence (i.e. primary structure) identity among the various homologs of TW K- 1 , and indeed among all ofthe known potassium transport channels is very low, approximately 25-28%. However, the presence and organization of three specific domains of TWDC-l and its homologous sequences TREK-1, TASKl and TASK2 distinguish these polypeptides from other groups of channels, e.g., the BRK and Shaker proteins. On the basis of this structural similarity, these proteins can be considered to represent a new family of mammalian potassium transport channels, referred to as the 2P family of transport channels. Members of the 2P family are unique in that they possess four transmembrane domains, whereas the IRK and Shaker polypeptides contain 2 and 6 transmembrane domains, respectively. Second, the 2P family of proteins are the only potassium channels that are known to possess two P domains. Indeed, the highest degree of sequence identity observed among the various members of the2P family of channels occurs within these P regions. Thirdly, all members ofthe 2P family are distinguished by the presence of an extended MlPl interdomain. This peculiar domain has been shown to be extracellular in the case of TWTK-l and to be important for the self-association of two TWDC-l subunits. The TWDC-l hαmodimers are covalent because ofthe presence of an interchain disulfide bridge between cysteine residues(i.e., amino acid residue 69) located in the MlPl interdomain (Lesage et al, 1996b). This cysteine residue is conserved in TREK-1 (residue 93) and TASK2 (residue 51), but not in TASKl. This suggests that TASKl may not form covalent dimers as observed for TWD 1 (Lesage et al , 1996b), TREK-1 and TASK2. Novel Characteristics of TASK-2. TASK-2 is a novel member of the emerging family of 2P domain K + channels. Its cloning extends to five the number of these channels identified to date in mammals. Despite an overall structure conservation, TASK-2 does not share more than 18-22% of amino acid identity with the four other cloned channels and does not seem to be more related to any one of them from a phylogenetic point of view. Both the Shaker and IRK families of K channel subunits comprise numerous distinct proteins encoded for by different genes. Within each of these two superfamilies, different subclasses can be distinguished according to their sequence similarities. Moreover, sequence conservation within each family is associated with similar functional properties. For instance, within the IRK family, the Kir3.x subunits share 55-60% of amino acid identity (28). All these Kir3.x proteins form G-protein-activated + channels. Kir subunits belonging to the other subgroups are more distant from the point of view of sequences and form inward rectifier channels that are not activated by G-proteins (29-31). On the other hand, the iS/røAer-related voltage-dependent Kvl.x K + channels (32-34) or the Ca 2+ -dependent SK channels (35) form subsets of proteins sharing 70-85% of amino acid identity. However, in spite of a si ilar structure with 6 TMS and one P domain, Kvl .x and SK channels have less than 20% of overall amino acid identity. The question then arises to know whether equivalent structural and functional subfamilies can be distinguished in the 2P domain K + channel family. With a low sequence conservation between the different channels cloned up till now (18-38% of identity), the usual criteria of sequence similarity cannot be used. Nevertheless, our work leads to propose a fimctional classification. TWDC-l forms a first functional group because it is the only one to express weakly inward rectifying currents. TREK-1 and TRAAK form a second group of channels that produce outwardly rectifying currents stimulated by arachidonic acid and polyunsaturated fatty acids (10, 12, 19). The fact that both channels share 38% of amino acid identity instead of the 18-22% of identity usually found between the 2P domain K* channels could signify that they have evolved from a common ancestral gene. However, TREK- 1 and TRAAK probably have different physiological sigmficances, since they have quite different tissue distributions as well as different eiectrophysiological and regulation properties. The quasi- ubiquitous TREK-1 channel is inhibited by cAMP, but not the neuronal TRAAK channel. TRAAK loses its outward rectification in high external [K ] but not TREK- 1. The last functional group of 2P domain I channels is composed of TASK-l and TASK-2. Both channels produce open rectifier K + currents that are inhibited by a drop of external pH in the physiological range (11, 13). Their pharmacological behaviors are also similar. TASK-2, as TASK-l, is relatively insensitive to classical K + channel blockers such as Ba 2+ , Cs + , TEA, and 4-AP, and both TASK- 1 and TASK-2 are blocked by the local anesthetics lidocaine and bupivacaine. Their sequences are only distantly related and for this reason, it is extremely difficult to know whether they have evolved from a common gene coding for an ancestral pH-sensitive K + channel. TASK-l and TASK-2 have different tissue distributions. TASK-l is widely expressed in excitable as weU as non-excitable tissues (11), while TASK-2 seems to be preferentially present in epithelia. They also show significant differences in terms of eiectrophysiological and regulation properties. Unlike TASK-l activity, TASK-2 activity is not inhibited by variations of intracellular cAMP (13), and TASK-2 is the sole 2P domain K * channel cloned to date that displays relatively slow activation kinetics (11, 13, 14). TASK-2 message is poorly expressed or absent in the nervous and muscular systems but is present in epithelial tissues such as lung, colon, intestine, stomach, liver, and particularly in the kidney. In kidney, TASK-2 is more precisely located in the cortical distal tubules and collecting ducts. In these structures, K + -selective currents are postulated to play a major role in the volume regulation and in the control o the negative potential of tubule cells, in K ÷ recycling across the basolateral membranes in coηj unction with the Na-K- ATPase, and in the K + secretion into the tubular lumen in concert with Na + influx through arhiloride- sensitive Na + channels (for reviews, see (3, 36)). Principal cells ofthe collecting ducts express at least two types of apical K + currents sharing common properties, such as inhibition by Ba 2"1" and ATP, as well as by internal acidification (3). The first one is a * channel with a large conductance and a low probability of opening, that is activated by membrane depolarization and internal Ca 2+ , and that is inhibited by TEA (37, 38). The second one is a small conductance (25 pS) K 1" channel with a high Po and inward rectification and that is insensitive to TEA (3, 40). A cloned K τ channel that has the same properties is ROMK2 (41). On the other band, three other K + cuτrents have been described at the basolateral membrane ofthe collecting duct cells: a small conductance K + channel (28 pS) up-regulated by protein kinase C, nitric oxide (NO) and cGMP (36, 42, 43), an intermediate conductance (85 pS) K + channel activated by protein kinase A and hyperpolarization (44), and a large conductance (147 pS) K + channel (42). However, the principal biophysical and pharmacological properties of TASK-2 do not fit those of these native K* channels. A possibility would be that TASK-2 channels are present in kidney cells but have not yet been recorded, which would not be surprising because of the lack of a specific pharmacology. Anotherpossibility would be that TASK-2 associates with yet unidentified pore- forming subunits or regulatory proteins to produce an active channel in native cells with properties different from those ofthe cloned channel as it has been observed for some other K + channels (45-47). The inhibition of newly cloned K τ channels by acidification is consistent with the effect of metabolic acidosis which decreases K * secretion in distal tubules (36). New insights into the mechanism of K + secretion have been recently provided by the cloning of several renal K + channels and by fine studies of their distribution and cellular localization. The present invention relates to four different areas : (i) identification ofthe native renal K + channel with the properties of TASK-2, (ii) identification of potent pharmacology that specifically modulates the activity of the TASK-2 channel, (iii) localizing K+ channels comprising the TASK2 subunit in vivo, and (iv) the generation of mice in which the TASK2 gene has been inactivated. In addition, genetic diseases associated with potassium transport channel deficiencies or malfunction are now being discovered with an increasing frequency (48). Therefore, the present invention also relates to diagnostic tests and therapeutic methods to (i) detect and treat human hypertensi on and diseases that are associated with kidney, pancreas and/or liver dysfunctions that may arise from mutations in the TASK-2 gene, (ii) protect against tissue rejection in kidney, pancreas and liver transplants, and (iii) identify new potential drugs capable of modulating the activity of TASK2. Thus, the object ofthe present invention are isolated, purified nucleic acid molecules, each of which encodes a protein constituting a potassium channel of the 2P family and/or exhibiting the properties and structure ofthe type ofthe TWDC-l channel described above. More specifically, the said nucleic acid molecule codes for the TWDC-l protein, the amino acid sequence of which is represented in the attached sequence list as number SEQ ID NO: 2, TASKl, represented in the attached sequence list as number SEQ ED NO: 4, TASK2 represented by SEQ DD NO: 28, or functionally equivalent derivatives of these sequences that possess the distinguishing structural features ofthe 2P family of potassium transport proteins. Such derivatives can be obtained by modifying and or suppressing one or more amino acid residues of this sequence, as long as this modification and/or suppression does not modify the functional properties of the TWDC-l potassium channel of the resultant protein. The sequences ofthe DNA molecules coding for the 2P proteins of the invention are represented in the attached sequence list as number SEQ ID NO: 1 (TWDC-l), SEQ ED NO: 3 (TASKl), and SEQ ED NO:27 (TASK2). The invention also relates to a vector containing a molecule ofthe aforementioned nucleic acid sequences, as weU as a procedure for the production or expression in a cellular host of a protein constituting a 2P potassium channel or a channel ofthe same family as TWDC-l. Aprocedure for production of a protein constituting a 2P potassium channel or exhibiting the properties and structure ofthe type ofthe TWDC-l channel consists of: - transferring a nucleic acid molecule of the invention or a vector containing the said molecule into a cellular host, - culturiπg the cellular host obtained in the preceding step under conditions enabling the production of potassium channels exhibiting the properties of TWDC-l, -isolating the proteins constituting the potassium channels o the 2P family. A procedure for the expression of a TWDC- 1 potassium channel or a potassium channel ofthe same family as TWDC-l consists of: - transferring a nucleic acid molecule of the invention or a vector containing the said molecule into a cellular host, - culturing the cellular host obtained in the preceding step under conditions enabling the expression of potassium channels ofthe 2P family. The ceUular host employed in the preceding procedures can be selected from among the prokaryotes or the eukaryotes, and notably from among the bacteria, the yeasts, mammal cells, plant cells or insect cells. The vector used is selected in relation to the host into which it will be transferred; it can be any vector such as a plasmid. The mvention thus also relates to the transferred cells expressing the potassium channels exhibiting the properties and structure ofthe type ofthe TWDC-l channel obtained in accordance with the preceding procedures. The cells expressing TWDC-l potassium channels or channels exhibiting the properties and structure ofthe type of the TWDC-l channels obtained in accordance with the preceding procedures are useful for the screening of substances capable of modulating the activity of the individual members ofthe TWDC-l family of potassium channels. This screening is carried out by bringing into contact variable amounts of a substance to be tested with cells expressing the TWDC-l channel or potassium channels exhibiting the properties and structure ofthe type ofthe TWDC- 1 channels, then determining the effects of said substance on the currents ofthe potassium channels of these channels. This screening procedure makes it possible to identify drugs that may be useful in the treatment of diseases of the heart or of the nervous system. Diseases involving the potassium channels and thus likely to involve the channels ofthe TWDC-l family are, for example, epilepsy, heart (arrhythmias) and vascular diseases, neurodegenerative diseases, kidney, liver orpancreas diseases, hypertension, and diseases associated with ischemia or anoxia, the endocrine diseases associated with anomalies of hormone secretion, muscle diseases. An isolated, purified nucleic acid molecule coding for a protein of the 2P family of potassium channel or a vector including this nucleic acid molecule or a cell expressing the potassium channel polypeptide, are also useful for thepreparation of transgenetic animals. These can be animals supra-expressing said channels, but especially so-called knock-out animals, i.e., animals presenting a deficiency of these channels; these transgenetic animals are prepared by methods known to the experts in the field, and enable the preparation of live models for studying animal diseases associated with the 2P family o f channels. The nucleic acid molecules ofthe invention or the cells transformed by said molecule can be used in genetic therapy strategies to compensate for a deficiency in the potassium channels at the level of one or more tissues of a patient. The invention thus also relates to a medication containing nucleic acid molecules of the invention or cells transformed by said molecule for the treatment of disease involving the potassium channels. In addition, the gene of the TWTK-l channel has been located on chromosome 1 at position q42-q43. The chromosomal localization of this gene constitutes a determinant result for the identification of genetic diseases associated with this new family of potassium channels; thus, the knowledge ofthe structure ofthe TWTK-l family of channels is such as to allow performance of a prenatal diagnosis of such diseases. The TASK! and TASK2 genes have also been localized on the human genome and are useful for diagnosis of genetic diseases involving these loci. The present invention also has as its object a new family of K+ channels, of which TWDC-l, TASKl and TASK2 are members, which polypeptides are present in most human tissues, but especially abundant in the brain, kidney or the heart, and which exhibit the properties and structure ofthe type of those of the TWDC- 1 channels described above. Thus it relates to an isolated, purified protein whose amino acid sequence is represented in the attached sequence list as number SEQ DD NO: 2, SEQ ED NO: 4, or SEQ ID NO:28, or a functionally equivalent derivative of these sequences. Such derivatives can be obtained by modifying and/or suppressing one or more amino acid residues of this sequence or by segmenting this sequence, as long as this modification and or suppression or deletion of a fragment does not modify the functional properties ofthe TWDC-l type potassium channel ofthe resultant protein. A protein constituting a 2P potassium channel is useful for the manufacture of medications intended for the treatment or prevention of diseases involving dysfunction of the potassium channels. Polyclonal or monoclonal antibodies directed against a protein constituting a 2P potassium channel can be prepared by the conventional methods described in the literature. These antibodies are useful for mvestigating the presence of potassium channels of he 2P family in different human or animal tissues, but can also be applied for the in vivo inhibition or activation of 2P potassium channels.

Claims: We Claim: 1. An isolated nucleic acid encoding a mammalian protein which is competent to transport potassium across a membrane, said transport being regulated by external pH, which protein is highly expressed in kidney and comprises two P domains and four transmembrane segments. 2. The nucleic acid of claim 1 encoding a human protein which exhibits non- inactivating outwardly rectifying potassium currents. 3. The nucleic acid of claim 1 which is also expressed to a lesser extent in the pancreas, the liver, the placenta, and the small intestine. 4. The human nucleic acid sequence of claim 3 which is represented by SEQ ED No . 5. An isolated mammalian protein which is competent to transport potassium across a membrane, said transport being regulated by external pH, which protein comprises two P domains and four transmembrane segments, and is highly expressed in kidney. 6. The protein of claim 5 that is predominantly expressed in the distal tubules and collecting ducts of he kidney. 7. The protein of claim 5 which is expressed preferentially in epithelia and is poorly expressed in nervous and muscular tissue. 8. The protein of claim 5 whose transport activity is regulated by external pH in the physiologic range. The protein of claim 5 which is human. 10. The protein of claim 9 which exhibits non-inactivating outwardly rectifying potassium currents. 11. The protein of claim 10 whose potassium transport is 50% inhibited by 22μM quinine. 12. The protein of claim 10 whose potassium transport is 65% inhibited by lOOμM quinidine. 13. The protein of claim 10 whose potassium transport is not inhibited by ImM tetraethylammonium, 100μM4-aminopyridine, ImM Cs + , or intracellular cAMP. 14. The protein of claim 9 which comprises the sequence represented by SEQ ED No. 6. 15. A self replicating vector comprising the nucleic acid molecule of claim 1. 16. A cell transformed with the vector of claim 15, which cell expresses a human protein which is competent to transport potassium across a membrane, said transport being regulated by external pH, which protein is highly expressed in kidney and comprises two P domains and four transmembrane segments. 17. The transformed cell of claim 16, which cell is selected from the group consisting of prokaryotes and eukaryotes. 18. The transformed cell of claim 17 which is a bacterium. 1 . The transformed cell of claim 17 which is a yeast, insect, plant or mammalian cell. 20. A eukaryotic cell micro-injected with a nucleic acid molecule encoding TASK2, which cell expresses a protein which is competent to transport potassium across a membrane, said transport being regulated by external pH, and which protein comprises two P domains and four transmembrane segments. 21. The cell of claim 17 wherein the micro-injected nucleic acid is the RNA transcript synthesized from the nucleic acid of claim 1. 22. A method for the production of a human protein which is competent to transport potassium across a membrane and which is comprised of two P domains and four transmembrane segments, comprising transferring the vector of claim 10 into a cellular host, culturing the host under conditions enabling the expression of said potassium channel, and purifying the human potassium channel. 23. The method of claim 22 wherein the cellular host is selected from the group consisting of prokaryotes and eukaryotes. 24. The method of claim 23 wherein the cellular host is a bacterium. 25. The method of claim 23 wherein the ceUular host is a yeast, insect, plant or mammalian cell. 26. A method for identifying substances which are capable of modulating the potassium transport activity ofthe protein of claim 5 comprising bringing into contact variable amounts of a substance to be tested with cells expressing said potassium channel and determining the effects ofthe substance on the potassium transport properties of die channel. 27. A pharmaceutical composition for the treatment of hypertension or dysfunctions of the kidney, liver or pancreas which comprises an isolated human nucleic acid molecule encoding the protein represented by SEQ ID No.6. 28. A pharmaceutical composition comprising human cells transformed with a nucleic acid encoding the protein represented by SEQ DD No. 6, which ceUs express the TASK2 channel and are competent to transport potassium across a membrane, said transport being regulated by external pH. 29. The pharmaceutical composition of claim 28 wherein the cells are micro- injected with a nucleic acid encoding the protein represented by SEQ ED No.6. 30. A method for modulating potassium transport activity of the protein of claim 5 comprising reacting mammalian cells expressing said protein with an antibody reactive against the protein represented by SEQ DD No. 6. 31. A diagnostic test to detect hypertension or diseases ofthe kidney, pancreas and/or liver that arise from mutations in the gene comprising the sequence represented by SEQ DD. No. 5, comprising hybridizing the sequence of claim 1 with an unknown sample of human nucleic acid. 32. The diagnostic test of claim 31 wherein the hybridization is carried out under stringent conditions (50% aqueous formamide at 45°C). 33. The diagnostic test of claim 31 wherein the hybridization is carried out under non-stringent conditions (6 X SSC, 5 X Denhardt's solution at 60°C). 34. The diagnostic test of claim 1 where the human nucleic acid is comprised of intact, isolated chromosomes. 35. The diagnostic test of claim 34 wherein the gene comprising the sequence represented by SEQ ID. No. 5 is amplified by PCR prior to hybridization with the sequence of claim 1. 36. A diagnostic test to identify the TASK2 potassium channel in a tissue sample comprising reacting said tissue with an antibody reactive against the protein represented by SEQ ID No. 6.

Inventors: DUPRAT FABRICE, LAZDUNSKI MICHEL, LESAGE FLORIAN, DUPRAT, FABRICE, LAZDUNSKI, MICHEL, LESAGE, FLORIAN
Applicants: CENTRE NAT RECH SCIENT, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE - CNRS
Application year: 1999
Main classification: C07K14
IPC codes: C07K14